SERA (Sera Prognostics Inc.) Company Cash Funds

Graphic logo of Sera Prognostics, Inc. (SERA)

Sera Prognostics is automating proteomic analysis to identify pregnancy risks by eliminating human error. The developed preterm birth test ensures stable demand from clinics. The cash position demonstrates liquidity, while the value of 0.04 captures the metric level. The uniqueness of the diagnostics provides the company with pricing power, which simplifies negotiations for insurance coverage of services.

Company Cash Balance: Sera Prognostics, Inc. (SERA) for 07/04/2022 - 11/21/2026

SERA (Sera Prognostics Inc.): analytical breakdowns and indicator data

- current price and projected stock value:
- business market valuation indicators:
Summary company analytics:SERA seraprognostics.com
Brand item of Sera Prognostics, Inc.

Sera Prognostics maintains a high-tech laboratory in Utah featuring strict climate control and backup power supplies. The current value of 0.04 reflects the total balance of liquid assets available for operational management and the settlement of short-term liabilities. Excess capital may indicate inefficient resource allocation, whereas a deficit creates risks of cash flow gaps. By analyzing the volume of operational cash, an investor determines the balance between financial stability and asset yield.